BlackRock Health Sciences Term Trust Files Definitive Proxy Materials

TL;DR

BlackRock Health Sciences Term Trust filed its definitive proxy statement, no new fee required.

AI Summary

BlackRock Health Sciences Term Trust (the Registrant) filed a DEFA14A, indicating it is providing definitive proxy materials. The filing is related to the company's proxy statement and does not require a new filing fee, as indicated by 'No fee required.' The company's fiscal year ends on December 31st, and it is incorporated in Maryland.

Why It Matters

This filing is a standard regulatory requirement for public companies to provide shareholders with information before a shareholder meeting, ensuring transparency in corporate governance.

Risk Assessment

Risk Level: low — This filing is a routine proxy statement, not indicating any unusual financial or operational risks.

Key Numbers

• 1231 — Fiscal Year End (Indicates the end of the company's financial reporting year.)

Key Players & Entities

• BlackRock Health Sciences Term Trust (company) — Registrant
• 0001785971 (company) — Central Index Key
• 1934 Act (company) — SEC Act
• 811-23466 (company) — SEC File Number

FAQ

Key Financial Figures

• $130m — proved the discount by 5.2%, generating $130m in value for shareholders2 Implemented

Filing Documents

• d843575ddefa14a.htm (DEFA14A) — 11KB
• g843575g08g08.jpg (GRAPHIC) — 474KB
• 0001193125-24-164919.txt ( ) — 665KB

From the Filing

HEALTH SCIENCES TERM TRUST BLACKROCK HEALTH SCIENCES TERM TRUST UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Definitive Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 BLACKROCK HEALTH SCIENCES TERM TRUST (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. Your Vote Matters BlackRock Health Sciences Term Trust (NYSE: BMEZ) BMEZs annual meeting is this Tuesday, June 25. The future of your Fund and your investment is on the linemake your voice heard today. BlackRock and your Board continue to deliver for you: Delivered total shareholder returns of 8.8% since 2023, more than doubling peers returns1 Improved the discount by 5.2%, generating $130m in value for shareholders2 Implemented a discount management program providing shareholders with an additional 9.8% of annual liquidity at NAV3 Your Board nominees are trusted fiduciaries with a strong track record of protecting your long-term investment Sabas track record is marked by self-interested actions: Sabas true aim is a quick profit for themselves at the expense of your Fund and shareholders like you Sabas nominees are underqualified, have zero closed-end fund expertise and are beholden to Sabas interests, not yours Saba has never launched a closed-end fundjust taken them over. At those funds, Saba pursued riskier strategies that may no longer serve the investment goals of shareholders and have resulted in increased fees and expenses How to vote: Follow email instructions to vote online and make your voice heard BEFORE the annual meeting on June 25. Leading independent proxy advisors back BlackRock: ISS and Glass Lewis recommend voting AGAINST terminating BlackRock as investment manager and FOR ALL Board nominees. Vote today: FOR the Boards Class II Board Member Nominees AGAINST Sabas proposal to terminate BlackRock as BMEZs investment manager ONLINE VOTING CLOSES AT 11:59 PM ET ON JUNE 24, 2024 ! IMPORTANT: Do NOT return any gold proxy card from Saba. Only your latest dated proxy card will count. If you have already sent back the proxy card received from Saba, you can still change your vote by promptly voting online or by phone by following the instructions on your WHITE proxy card, which will replace any prior vote you previously submitted If you have any questions about the proposals to be voted, please feel free to contact Georgeson LLC (Georgeson), toll free at 1-866-529-4033 Important information about the Fund This material is not an advertisement and is intended for existing shareholder use only. This document and the information contained herein relates solely to BlackRock Health Sciences Term Trust (BMEZ). The information contained herein does not relate to, and is not relevant to, any other fund or product sponsored or distributed by BlackRock or any of its affiliates. This document is not an offer to sell any securities and is not a solicitation of an offer to buy any securities. Common shares for the closed-end fund identified above are only available for purchase and sale at current market price on a stock exchange. A closed-end funds dividend yield, market price and NAV will fluctuate with market conditions. The information for this Fund is provided for informational purposes only and does not constitute a solicitation of an offer to buy or sell Fund shares. Performance results reflect past performance and are no guarantee of future results. Current performance may be lower or higher than the performance data quoted. All returns assume reinvestment of all dividends. The market value and net asset value (NAV) of a funds shares will fluctuate with market conditions. Closed-end funds may trade at a premium to NAV but often trade at a discount. © 2024 BlackRock, Inc. or its affiliates. All Rights Reserved. BLACKROCK is a trademark of BlackRock, Inc., or its affiliates. All other trademarks are those of their respective owners. BLACKROCK® 1 Morningstar as of 5/31/2024; Total shareholder return on price annualized for periods longer than 1 year (assumes dividends are reinvested); Peer set includes all closed-end funds in the Morningstar Health category (ex-BMEZ) 2 12/31/2022 5/31/2024; Morningstar/BlackRock data as of 5/31/2024 3 If the funds common shares trade at a discount of more than 7.5% during each of the quarters ended 6/30/24, 9/30/24, 12/31/24 and 3/31/25, the fund intends to of

View Full Filing

View this DEFA14A filing on SEC EDGAR